LUVICI
LIVE

Serial Number

79273188

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Sep 25, 2019

Add to watchlist:

No watchlists yet
View on USPTO

LUVICI Trademark

Serial Number: 79273188 • Registration: 6035995

LUVICI is a trademark filed by NOVARTIS AG on September 25, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,165 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

September 25, 2019

Registration Date

April 21, 2020

Published for Opposition

February 4, 2020

Goods & Services

Downloadable mobile software applications for use in disease treatment and tracking patient compliance with medical treatments

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Medical services, namely, providing healthcare information for patients and healthcare providers

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Apr 21, 2025 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Jun 10, 2022 NREP
NOTIFICATION PROCESSED BY IB
Jul 10, 2020 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Jun 22, 2020 FICS
FINAL DISPOSITION PROCESSED
Jun 22, 2020 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
May 21, 2020 GPAR
REGISTERED-PRINCIPAL REGISTER
Apr 21, 2020 R.PR
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 18, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 18, 2020 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Mar 18, 2020 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 18, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 18, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 18, 2020 COAR
PUBLISHED FOR OPPOSITION
Feb 4, 2020 PUBO
NOTICE OF PUBLICATION
Jan 15, 2020 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 28, 2019 CNSA
ASSIGNED TO EXAMINER
Dec 23, 2019 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 17, 2019 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 13, 2019 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 12, 2019 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 5, 2019 REPR